EDIT June 15 fda catalyst expected move?

Scouter tracks EDIT catalyst timing and historical price reactions to similar events. Upcoming bull/bear scenario levels are available to subscribers; this page shows past outcomes and event dates.

how volatile is EDIT stock before fda decision?

Scouter tracks EDIT catalyst timing and historical price reactions to similar events. Upcoming bull/bear scenario levels are available to subscribers; this page shows past outcomes and event dates.

EDIT fda approval expected stock move?

Scouter tracks EDIT catalyst timing and historical price reactions to similar events. Upcoming bull/bear scenario levels are available to subscribers; this page shows past outcomes and event dates.

EDIT (Editas Medicine, Inc.) — Stock Analysis, Catalysts & AI Research

Editas Medicine, Inc.

$2.76

Health CareBiotechnology

The Read: Editas Medicine’s stock has shown high volatility around FDA-related catalysts, with moves ranging from about 17% to 30% driven more by financial concerns like revenue misses and a $319.

Price

Overlays

Panel

EDIT

Hover to view data

No Data

The Stats

Market Cap

N/A

Total outstanding shares value

Earnings Per Share (EPS)

N/A

Latest reported

Net Profit Margin

N/A

Net Income / Revenue

Revenue Growth (YoY)

N/A

Prior year same period

Debt / Equity

N/A

Leverage risk indicator

Dividend Yield

0.00%

Annualized Return

Free Cash Flow

N/A

No data

Scouting Reports

The Fee-Growth Pivot: Wall Street Navigates Private Credit Risk and Regulatory Thaw

Apr 11, 2026

As the Financials sector enters a high-stakes earnings week starting April 13, the narrative is shifting away from the peak-rate environment that dominated the last two years. While net interest incom

Editas Medicine, Inc.

$2.76

Health CareBiotechnology

The Read: Editas Medicine’s stock has shown high volatility around FDA-related catalysts, with moves ranging from about 17% to 30% driven more by financial concerns like revenue misses and a $319.

Price

Overlays

Panel

EDIT

Hover to view data

No Data

The Stats

Market Cap

N/A

Total outstanding shares value

Earnings Per Share (EPS)

N/A

Latest reported

Net Profit Margin

N/A

Net Income / Revenue

Revenue Growth (YoY)

N/A

Prior year same period

Debt / Equity

N/A

Leverage risk indicator

Dividend Yield

0.00%

Annualized Return

Free Cash Flow

N/A

No data

Scouting Reports

The Fee-Growth Pivot: Wall Street Navigates Private Credit Risk and Regulatory Thaw

Apr 11, 2026

Create your free account to unlock active Expected Moves for EDIT

Expected Moves

Editas Medicine, Inc.

The Stats

Market Cap

Earnings Per Share (EPS)

Net Profit Margin

Revenue Growth (YoY)

Debt / Equity

Dividend Yield

Free Cash Flow

Scouting Reports

The Fee-Growth Pivot: Wall Street Navigates Private Credit Risk and Regulatory Thaw

Create your free account to unlock active Expected Moves for EDIT

Expected Moves

Editas Medicine, Inc.

The Stats

Market Cap

Earnings Per Share (EPS)

Net Profit Margin

Revenue Growth (YoY)

Debt / Equity

Dividend Yield

Free Cash Flow

Scouting Reports

The Fee-Growth Pivot: Wall Street Navigates Private Credit Risk and Regulatory Thaw